(Q82249610)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20012107%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

The complement component C3a fragment is a potential biomarker for hepatitis C virus-related hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20012107%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

1 reference

hepatocellular carcinoma

1 reference

1 reference

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20012107%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Shuji Kanmura

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20012107%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Hirofumi Uto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20012107%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Yuko Sato

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20012107%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Koutarou Kumagai

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20012107%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Fumisato Sasaki

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20012107%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Akihiro Moriuchi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20012107%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Makoto Oketani

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20012107%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Akio Ido

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20012107%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Kenji Nagata

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20012107%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Katsuhiro Hayashi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20012107%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Hirohito Tsubouchi

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20012107%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

publication date

9 December 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20012107%20AND%20SRC:MED&resulttype=core&format=json

Journal of Gastroenterology

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20012107%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20012107%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20012107%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

459-467

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20012107%20AND%20SRC:MED&resulttype=core&format=json

Increased serum levels of complement C3a anaphylatoxin indicate the presence of colorectal tumors

15 January 2020

cites work

1 reference

12 December 2020

Clinical evaluation of lentil lectin-reactive alpha-fetoprotein-L3 in histology-proven hepatocellular carcinoma

1 reference

12 December 2020

A strategy for the comparative analysis of serum proteomes for the discovery of biomarkers for hepatocellular carcinoma

1 reference

12 December 2020

The role of tumor markers in the diagnosis of hepatocellular carcinoma, with special reference to the des-gamma-carboxy prothrombin

1 reference

12 December 2020

Increase of serum complement levels in cancer patients with progressing tumors

1 reference

12 December 2020

Identification of serum biomarkers for colon cancer by proteomic analysis

1 reference

12 December 2020

Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group

1 reference

12 December 2020

Ascitic complement system in ovarian cancer

1 reference

12 December 2020

Early diagnostic potential for hepatocellular carcinoma using the SELDI ProteinChip system

1 reference

12 December 2020

Steatosis, liver injury, and hepatocarcinogenesis in hepatitis C viral infection

1 reference

12 December 2020

Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels

1 reference

12 December 2020

Spontaneous elimination of hepatitis C virus RNA in individuals with persistent infection in a hyperendemic area of Japan

1 reference

12 December 2020

Hepatocellular carcinoma

1 reference

12 December 2020

Discovery and identification of potential biomarkers in a prospective study of chronic lymphoid malignancies using SELDI-TOF-MS.

1 reference

12 December 2020

SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma.

1 reference

12 December 2020

Rapid discovery and identification of a tissue-specific tumor biomarker from 39 human cancer cell lines using the SELDI ProteinChip platform.

1 reference

12 December 2020

Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis

1 reference

12 December 2020

Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.

1 reference

12 December 2020

C3a and C3b activation products of the third component of complement (C3) are critical for normal liver recovery after toxic injury

1 reference

12 December 2020

Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease

1 reference

12 December 2020

Oval cell proliferation in cirrhosis in rats. An experimental study

1 reference

12 December 2020

Serum levels of des-gamma-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma

1 reference

12 December 2020

Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCV-related hepatocellular carcinoma using a proteomics approach.

1 reference

12 December 2020

Structure and biology of complement protein C3, a connecting link between innate and acquired immunity

1 reference

12 December 2020

Differential gene expression between chronic hepatitis B and C hepatic lesion

1 reference

12 December 2020

Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases

1 reference

12 December 2020

Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry

1 reference

12 December 2020

Complement resistance of tumor cells: basal and induced mechanisms.

1 reference

12 December 2020

Serum proteome profiles identifies parathyroid hormone physiologic response.

1 reference

12 December 2020

Proteomic analysis of sera from hepatocellular carcinoma patients after radiofrequency ablation treatment

1 reference

12 December 2020

Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma

1 reference

12 December 2020

Effect of time, temperature and anticoagulants on in vitro complement activation: consequences for collection and preservation of samples to be examined for complement activation

1 reference

12 December 2020

Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients

1 reference

12 December 2020

Hepatocellular carcinoma: overcoming challenges in disease management

1 reference

12 December 2020

The usefulness of determining des-gamma-carboxy prothrombin by sensitive enzyme immunoassay in the early diagnosis of patients with hepatocellular carcinoma

1 reference

12 December 2020

Rising incidence of hepatocellular carcinoma in the United States

1 reference

12 December 2020

alpha-Fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma

1 reference

12 December 2020

Usefulness of serum des-gamma-carboxy prothrombin in detection of hepatocellular carcinoma

1 reference

12 December 2020

Efficacy and safety of 6-month iron reduction therapy in patients with hepatitis C virus-related cirrhosis: a pilot study

1 reference

12 December 2020

Evaluation of tumor markers for the detection of hepatocellular carcinoma in Yangon General Hospital, Myanmar

1 reference

12 December 2020

Comparison of proteome between hepatitis B virus- and hepatitis C virus-associated hepatocellular carcinoma.

1 reference

12 December 2020

10.1007/S00535-009-0160-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20012107%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference